Form 4: Exelon Director Charisse R. Lillie Reports Stock Acquisition

Charisse R. Lillie, a director of Exelon Corp, reported the acquisition of 1,025 shares of common stock through the Exelon Corp. Directors Deferred Stock Unit Plan on September 30, 2024.

Summary

• On September 30, 2024, Charisse R. Lillie, a director of Exelon Corp, acquired 1,025 shares of common stock through the Exelon Corp. Directors Deferred Stock Unit Plan at a price of $40.23 per share.
• Following the transaction, Lillie directly owns 7,246 shares of Exelon common stock and indirectly owns 6,288 shares through the Exelon Corp. Directors Deferred Stock Unit Plan.
• Lillie also holds 3,656 deferred phantom share equivalents in Exelon's stock fund account, which is part of a non-qualified deferred compensation plan.
• These phantom share equivalents will be settled for cash upon the termination of Lillie's service to the board.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any explicit positive or negative sentiment about the company's performance or prospects.

Positives

• The acquisition of shares by a director could be interpreted as a sign of confidence in the company's future prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding Exelon's future performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activity.

Key Dates